» Articles » PMID: 37946137

Leptospirosis-associated Meningitis in a Patient with Sjögren's Syndrome: a Case Report

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2023 Nov 10
PMID 37946137
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Leptospirosis is a zoonotic disease that afflicts both humans and animals. It progresses from flu-like symptoms to more severe hepatic and renal failure, and may also lead to aseptic meningitis. Individuals with autoimmune diseases (ADs) are potentially more susceptible to Leptospirosis. Thus far, limited data has documented the association between Leptospirosis and autoimmune disorders.

Case Presentation: The patient had a definitive pathological diagnosis of Sjögren's syndrome (SS). Due to recurrent headaches, the patient sought consultation with a neurologist. Lumbar puncture revealed elevated white blood cells and protein levels in the cerebrospinal fluid, along with decreased glucose. Tuberculous meningitis was suspected. Radiographic imaging exhibited meningeal enhancement, ventricular enlargement, and hydrocephalus. The patient commenced treatment with anti-tuberculosis therapy and corticosteroids. Subsequently, high-throughput sequencing (HTS) of cerebrospinal fluid identified the presence of Leptospira interrogans. The patient was ultimately diagnosed with Leptospiral meningitis, and underwent antimicrobial and immunosuppressive therapy, resulting in stabilization of the condition and gradual symptom recovery.

Conclusions: The case highlights the challenges in diagnosing and managing leptospirosis-related meningitis in the presence of ADs and emphasizes the importance of utilizing HTS for accurate pathogen detection. The potential correlation between leptospirosis and SS warrants further investigation, as does the need for multidisciplinary involvement in treatment strategies for such complex cases.

Citing Articles

Atypical Cases of Leptospirosis: Insights From Georgia.

Dehkordi A, Al-Tamary S, Al-Tamary A, Al-Tamary H, Albarari S, Assad A Case Rep Infect Dis. 2024; 2024:1414417.

PMID: 39610672 PMC: 11602529. DOI: 10.1155/2024/1414417.


A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System.

Alexopoulou C, Proklou A, Kokkini S, Raissaki M, Konstantinou I, Kondili E Healthcare (Basel). 2024; 12(5).

PMID: 38470679 PMC: 10931561. DOI: 10.3390/healthcare12050568.

References
1.
Carbone J, del Pozo N, Gallego A, Sarmiento E . Immunological risk factors for infection after immunosuppressive and biologic therapies. Expert Rev Anti Infect Ther. 2011; 9(4):405-13. DOI: 10.1586/eri.10.178. View

2.
Tattevin P, Dupeux S, Hoff J . Leptospirosis and the antiphospholipid syndrome. Am J Med. 2003; 114(2):164. DOI: 10.1016/s0002-9343(02)01365-7. View

3.
Zhang L, Chen F, Zeng Z, Xu M, Sun F, Yang L . Advances in Metagenomics and Its Application in Environmental Microorganisms. Front Microbiol. 2022; 12:766364. PMC: 8719654. DOI: 10.3389/fmicb.2021.766364. View

4.
Mathew T, Satishchandra P, Mahadevan A, Nagarathna S, Yasha T, Chandramukhi A . Neuroleptospirosis - revisited: experience from a tertiary care neurological centre from south India. Indian J Med Res. 2006; 124(2):155-62. View

5.
Ko A, Goarant C, Picardeau M . Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol. 2009; 7(10):736-47. PMC: 3384523. DOI: 10.1038/nrmicro2208. View